Romilkimab Uses, Dosage, Side Effects and more
Romilkimab is under investigation in clinical trial NCT02345070 (Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis).
| Trade Name | Romilkimab |
| Generic | Romilkimab |
| Romilkimab Other Names | Hutbti3_2_1, Romilkimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
